טוען...
Study partner types and prediction of cognitive performance: implications to preclinical Alzheimer’s trials
BACKGROUND: Alzheimer’s disease (AD) clinical trials require enrollment of a participant and a study partner, whose role includes assessing participant cognitive and functional performance. AD trials now investigate early stages of the disease, when participants are not cognitively impaired. This gi...
שמור ב:
| הוצא לאור ב: | Alzheimers Res Ther |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6881999/ https://ncbi.nlm.nih.gov/pubmed/31775871 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-019-0544-6 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|